Page last updated: 2024-12-05

trifluoroacetic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Trifluoroacetic Acid: A very strong halogenated derivative of acetic acid. It is used in acid catalyzed reactions, especially those where an ester is cleaved in peptide synthesis. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

trifluoroacetic acid : A monocarboxylic acid that is the trifluoro derivative of acetic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6422
CHEMBL ID506259
CHEBI ID45892
SCHEMBL ID474
MeSH IDM0021957

Synonyms (115)

Synonym
nsc 77366
ai3-28549
einecs 200-929-3
kyselina trifluoroctova [czech]
trifluoracetic acid
brn 0742035
un2699
NCIOPEN2_000728
perfluoroacetic acid
nsc-77366
nsc77366
trifluoroethanoic acid
76-05-1
wln: qvxfff
inchi=1/c2hf3o2/c3-2(4,5)1(6)7/h(h,6,7
TFA ,
acetic acid, trifluoro-
trifluoroacetic acid
trifluoroacetic acid, reagentplus(r), 99%
CHEBI:45892 ,
trifluoressigsaeure
1W70
copper(ii) trifluoroacetate hydrate
acid, trifluoroacetic
ipc-pffa-2
Q0053
T0431
2,2,2-trifluoroacetic acid
CHEMBL506259
AKOS000118999
2,2,2-trifluoro-acetic acid
trifluoro acetic acid
trifluoroacetyloxy
trifluoro-acetic acid
trifluoroacetic acid, biochemical grade
cf3cooh
acetic acid-d, trifluoro-
unii-e5r8z4g708
e5r8z4g708 ,
4-02-00-00458 (beilstein handbook reference)
acetic acid, 2,2,2-trifluoro-
kyselina trifluoroctova
hsdb 7508
trifluoroacetic acid [un2699] [corrosive]
ec 200-929-3
FT-0645072
trifluoroacetic acid [ii]
trifluoroacetic acid [hsdb]
trifluoroacetic acid [mi]
STL264183
BP-20560
SCHEMBL474
CS-B0890
tri-fluoroacetic acid
2,2,2-trifluoracetic acid
f3ccooh
1,1,1 trifluoroacetic acid
trifluoroacetic aicd
f3cco2h
trifluoro aceticacid
trifluoroacetic-acid
tri-fluoro acetic acid
triflouroacetic acid
triflouro acetic acid
trifluroacetic acid
trifloroacetic acid
cf3c(o)oh
trifluoraceticacid
trifiuoroacetic acid
trifluoroacteic acid
2,2,2,-trifluoroacetic acid
trifluoroactic acid
trifluroaceticacid
2,2,2-triflouroacetic acid
trifluoro- acetic acid
cf3co2h
trifluoroaceticacid
trifluoracetate
Q-201877
un 2699
DTXSID9041578 ,
mfcd00004169
trifluoroacetic acid (peptide grade)
F2190-0649
trifluoroacetic acid, puriss. p.a., for hplc, >=99.0% (gc)
trifluoroacetic acid, anhydrous, zero2(tm), >=99.0%
trifluoroacetic acid, analytical standard
trifluoroacetic acid, for hplc, >=99.0%
trifluoroacetic acid, >=99%, purified by redistillation, for protein sequencing
trifluoroacetic acid, for protein sequence analysis, >=99.5% (t)
trifluoroacetic acid, saj special grade, >=99.0%
bruker standard solvent, for maldi ms, 50% acn + 47.5% h2o + 2.5% tfa
jwcibkmujoqybu-uhfffaoysa-n
trifluoroacetic acid, uv hplc spectroscopic, 99.8%
trifluoroacetic acid, vetec(tm) reagent grade, 99%
trifluoroacetic acid, p.a., 99.8%
acide trifluoroacetique
trifluoroacetic acid (acd/name 4.0)
trifluoressigsaure
trifluoroacetic acid, >=99.995% trace metals grade
trifluoroacetic acid, peptide synthesis grade
trifluoroacetic acid, hplc grade
flurtamone tp1
Q412033
SB13471
AMY3605
trifluoroacetic acid, commercial grade
snofkgqeuymnce-uhfffaoysa-n
EN300-19296
qjdbnaanwgirnu-uhfffaoysa-o
perfluoro-n-ethanoic acid
perfluoroethane carboxylic acid
trifluoroethanonic acid
dtxcid7021578
trifluoroacetic acid (ii)

Research Excerpts

Overview

Trifluoroacetic acid (TFA) is a carboxylic acid, similar to acetic acid, used industrially and in laboratories. It leads to significant mass spectrometry signal suppression during electrospray ionization.

ExcerptReferenceRelevance
"Trifluoroacetic acid (TFA) is a persistent and mobile pollutant that is present ubiquitously in the environment. "( Insufficient evidence for the existence of natural trifluoroacetic acid.
De Silva, AO; Joudan, S; Young, CJ, 2021
)
2.32
"Trifluoroacetic acid (TFA) is a ubiquitous and extremely stable contaminant in the ambient environment and may be discharged during fluorochemical production processes. "( Distribution characteristics of trifluoroacetic acid in the environments surrounding fluorochemical production plants in Jinan, China.
Cui, J; Xie, G; Zhai, Z; Zhang, J, 2020
)
2.28
"Trifluoroacetic acid (TFA) is a commonly used mobile phase additive in liquid chromatography-mass spectrometry (LC-MS)-based biopharmaceutical characterization to enhance reversed-phase chromatographic performance of peptide separation; however, it leads to significant mass spectrometry signal suppression during electrospray ionization. "( Simple Addition of Glycine in Trifluoroacetic Acid-Containing Mobile Phases Enhances the Sensitivity of Electrospray Ionization Mass Spectrometry for Biopharmaceutical Characterization.
Kleinberg, A; Li, N; Mao, Y; Raidas, S; Zhao, Y, 2020
)
2.29
"Trifluoroacetic acid (TFAA) is a carboxylic acid, similar to acetic acid, used industrially and in laboratories. "( Trifluoroacetic acid: Three times the fluoride, three times the toxicity?
Corbett, B; Sun, C, 2018
)
3.37
"Trifluoroacetic acid (TFA) burns are an ill-defined entity due to a lack of reported sizable burns from this chemical. "( Full-Thickness Chemical Burn From Trifluoroacetic Acid: A Case Report and Review of the Literature.
Davis, DJ; Karanas, YL; Rajasingh, CM; Rochlin, DH, 2018
)
2.2
"Trifluoroacetic acid is a very strong carboxylic acid. "( Chemical burns caused by trifluoroacetic acid.
Bruze, M; Dahlin, J; Engfeldt, M; Hindsén, M; Isaksson, M; Mowitz, M; Svedman, C; Zimerson, E, 2013
)
2.14
"Trifluoroacetic acid (TFA) is a breakdown product of several hydrochlorofluorocarbons (HCFC), regulated under the Montreal Protocol (MP), and hydrofluorocarbons (HFC) used mainly as refrigerants. "( Sources, fates, toxicity, and risks of trifluoroacetic acid and its salts: Relevance to substances regulated under the Montreal and Kyoto Protocols.
Aucamp, PJ; Bornman, JF; Longstreth, J; Madronich, S; Solomon, KR; Velders, GJ; Wilson, SR, 2016
)
2.15
"Trifluoroacetic acid (TFA) is a stable organic pollutant with potential toxicity. "( [Prelimary study of TFA in surface water of some cities over China].
Wang, QY; Wang, XM, 2011
)
1.81
"Trifluoroacetic acid is a metabolite of the inhaled anesthetics halothane, desflurane and isoflurane as well as a major contaminant in HPLC-purified peptides. "( Trifluoroacetate is an allosteric modulator with selective actions at the glycine receptor.
Iyer, SV; John Mihic, S; Tipps, ME, 2012
)
1.82
"Trifluoroacetic acid (TFA) is a purification contaminant associated with pediocin PA-1 that interferes with Fourier transform infrared spectroscopy structural analysis. "( Replacement of trifluoroacetic acid with HCl in the hydrophobic purification steps of pediocin PA-1: a structural effect.
Gaussier, H; Lavoie, MC; Morency, H; Subirade, M, 2002
)
2.11
"Trifluoroacetic acid (TFA) is a commonly used additive in HPLC and LC-MS analysis of basic compounds. "( Simple means to alleviate sensitivity loss by trifluoroacetic acid (TFA) mobile phases in the hydrophilic interaction chromatography-electrospray tandem mass spectrometric (HILIC-ESI/MS/MS) bioanalysis of basic compounds.
Naidong, W; Shou, WZ, 2005
)
2.03
"Trifluoroacetic acid (TFA) is a common reagent in both solid-phase and solution peptide synthesis. "( Lability of N-alkylated peptides towards TFA cleavage.
Lee, MS; Shen, R; Urban, J; Vaisar, T, 1996
)
1.74
"Trifluoroacetic acid (0.1% w/v) is an excellent solvent for polypeptides, is volatile, and has a low absorbance of ultraviolet light of low wavelength. "( High-performance gel permeation chromatography of proteins and peptides on columns of TSK-G2000-SW and TSK-G3000-SW: a volatile solvent giving separation based on charge and size of polypeptides.
Irvine, GB; Shaw, C, 1986
)
1.71

Effects

ExcerptReferenceRelevance
"Trifluoroacetic acid (TFA) has been attracting increasing attention worldwide because of its increased environmental concentrations and high aquatic toxicity. "( Airborne trifluoroacetic acid and its fraction from the degradation of HFC-134a in Beijing, China.
Fang, X; Hu, J; Jin, H; Li, L; Lu, K; Martin, JW; Wu, J; Zhai, Z; Zhang, J, 2014
)
2.26

Actions

ExcerptReferenceRelevance
"Trifluoroacetic acid plays an important role in the reaction."( Palladium-catalyzed oxidative cyclization of tertiary enamines for synthesis of 1,3,4-trisubstituted pyrroles and 1,3-disubstituted indoles.
Guan, ZH; Lian, XL; Ren, ZH; Wang, YY, 2014
)
1.12

Treatment

Treatment with trifluoroacetic acid (TFA) (95 %) and scavengers such as triisopropylsilane and water for 2 h is sufficient to obtain a fully deprotected peptide alcohol. Treatment with 20 % hexafluoroisopropanol in dichloromethane renders a fully protected peptidealcohol that can be further modified at the C-terminus.

ExcerptReferenceRelevance
"Treatment with trifluoroacetic acid (TFA) (95 %) and scavengers such as triisopropylsilane and water for 2 h is sufficient to obtain a fully deprotected peptide alcohol, while treatment with 20 % hexafluoroisopropanol in dichloromethane renders a fully protected peptide alcohol that can be further modified at the C-terminus."( Functionalized Resins for the Synthesis of Peptide Alcohols.
Ferrer-Gago, FJ; Koh, LQ; Lane, DP, 2020
)
0.9
"Pretreatment with trifluoroacetic acid (TFA) and hexafluoroisopropanol (HFIP) at a 1:1 ratio is currently the method of choice to achieve solubility of polyGln peptides."( Unaided trifluoroacetic acid pretreatment solubilizes polyglutamine peptides and retains their biophysical properties of aggregation.
Burra, G; Thakur, AK, 2016
)
1.19
"On treatment with trifluoroacetic acid butenolide 14 undergoes N-Boc deprotection and condensation followed by an iminium ion activated intramolecular Diels-Alder cycloaddition to give the (+)-himbacine precursor 11 on reductive work up. "( Biomimetic total synthesis of (+)-himbacine.
Adlington, RM; Baldwin, JE; Cowley, AR; Tchabanenko, K, 2005
)
0.66

Toxicity

ExcerptReferenceRelevance
" The enzymes involved in the toxic metabolic pathway have been investigated in this study."( Rat liver metabolism and toxicity of 2,2,2-trifluoroethanol.
Dunbar, D; Fraser, JM; Kaminsky, LS; Seaman, M, 1992
)
0.28
" Administered TFE and TFAld were not toxic per se, since their toxicity and metabolism were inhibited by pyrazole."( 2,2,2-Trifluoroethanol intestinal and bone marrow toxicity: the role of its metabolism to 2,2,2-trifluoroacetaldehyde and trifluoroacetic acid.
Fraser, JM; Kaminsky, LS, 1988
)
0.48
"2,2,2-Trifluoroethanol (TFE), the toxic metabolite of the anesthetic agent fluoroxene, is further metabolized to trifluoroacetic acid, which accumulated to maximum serum concentrations 16 to 24 hr after TFE administration to rats."( Metabolism of 2,2,2-trifluoroethanol and its relationship to toxicity.
Fraser, JM; Kaminsky, LS, 1987
)
0.48
" No acute toxic effects (48 h) were observed up to 4 g/L TFA."( Uptake, toxicity, and effects on detoxication enzymes of atrazine and trifluoroacetate in embryos of zebrafish.
Frank, H; Giese, M; Pflugmacher, S; Steinberg, C; Wiegand, C, 2000
)
0.31
" TFA administered to rats did not induce adverse effects in an extended one-generation study and in a developmental toxicity study or induce genotoxic responses."( Mammalian toxicity of trifluoroacetate and assessment of human health risks due to environmental exposures.
Dekant, R; Dekant, W, 2023
)
0.91

Pharmacokinetics

The production and excretion of trifluoroacetic acid, the major urinary metabolite of HCFC-124, were simulated in rats and mice, but not in hamsters. The in vivo metabolic rate constants obtained in the gas-uptake simulation studies were used.

ExcerptReferenceRelevance
" The production and excretion of trifluoroacetic acid, the major urinary metabolite of HCFC-124, were also simulated in rats and mice, but not in hamsters, by the physiologically based pharmacokinetic model when the in vivo metabolic rate constants obtained in the gas-uptake simulation studies were used."( Gas-uptake pharmacokinetics and metabolism of 2-chloro-1,1,1,2-tetrafluoroethane (HCFC-124) in the rat, mouse, and hamster.
Anders, MW; Loizou, GD, 1995
)
0.57
"The in vivo metabolic rate constants for the metabolism of the chlorofluorocarbon replacement 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123) were determined for both male and female rats with a physiologically based pharmacokinetic model."( Gas-uptake pharmacokinetics of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123).
Anders, MW; Dekant, W; Loizou, GD; Urban, G,
)
0.13
" A physiologically based pharmacokinetic (PBPK) model was developed which included a gut compartment and a variable size fat compartment in addition to the standard flow-limited compartments."( Dose-dependent metabolism of 2,2-dichloro-1,1,1-trifluoroethane: a physiologically based pharmacokinetic model in the male Fischer 344 rat.
Fisher, JW; McDougal, JN; Vinegar, A; Williams, RJ, 1994
)
0.29
"The goal of this study was to develop a human physiologically based pharmacokinetic (PBPK) model for the chemical HCFC-123 (2,2-dichloro-1,1,1-trifluoroethane) and its major metabolite, trifluoroacetic acid (TFA)."( Rat to human extrapolation of HCFC-123 kinetics deduced from halothane kinetics: a corollary approach to physiologically based pharmacokinetic modeling.
Fisher, JW; Jarabek, AM; McDougal, JN; Vinegar, A; Williams, RJ, 1996
)
0.48
" A physiologically based pharmacokinetic model describing the concentration-dependent reduction in uptake and metabolism of halothane in male and female rats was developed."( Physiologically based pharmacokinetic analysis of the concentration-dependent metabolism of halothane.
Anders, MW; Loizou, GD; Tran, CL, 1997
)
0.3
" The methods were utilized to support clinical pharmacokinetic studies in infants aged 0-12 months."( Determination of famotidine in low-volume human plasma by normal-phase liquid chromatography/tandem mass spectrometry.
Eisenhandler, R; Yeh, KC; Zhong, L, 2001
)
0.31
" The developed method was successfully applied to the pharmacokinetic study of bis(12)-hupyridone after intravenous administration of 5mg/kg and intraperitoneal administration of 10 and 20mg/kg in rats."( Development and validation of an HPLC-DAD method for bis(12)-hupyridone and its application to a pharmacokinetic study.
Carlier, PR; Chan, K; Cheung, MC; Gu, ZM; Han, YF; Huang, M; Li, WM; Wang, YT; Yu, H; Zuo, Z, 2009
)
0.35
" Finally this validated method was successfully applied to a pharmacokinetic study in dogs and monkeys after oral administration of 10 mg/kg AST."( A novel HPLC-MS/MS method for the simultaneous determination of astemizole and its major metabolite in dog or monkey plasma and application to pharmacokinetics.
Back, HM; Chae, JW; Kwon, KI; Lee, JH; Seo, JW; Song, B; Yun, HY, 2015
)
0.42
" All 3 pharmacodynamic end points (luteinizing hormone, follicle-stimulating hormone, and total testosterone) showed reductions that were more prolonged following the 90 mg IM administration compared to 90 mg SC administration."( Pharmacokinetic, Safety, and Pharmacodynamic Properties of Teverelix Trifluoroacetate, a Novel Gonadotropin-Releasing Hormone Antagonist, in Healthy Adult Subjects.
Godsafe, Z; Larsen, F; MacLean, CM; Soto-Forte, P, 2022
)
0.72

Compound-Compound Interactions

ExcerptReferenceRelevance
"Sulfuric acid hydrolysis according to the Saeman procedure, TFA hydrolysis, and methanolysis combined with TFA hydrolysis were compared for the hydrolysis of water-soluble uronic acid-containing polysaccharides originating from fungi, plants, and animals."( Carbohydrate analysis of water-soluble uronic acid-containing polysaccharides with high-performance anion-exchange chromatography using methanolysis combined with TFA hydrolysis is superior to four other methods.
De Ruiter, GA; Rombouts, FM; Schols, HA; Voragen, AG, 1992
)
0.28
" Capillary electrophoresis in combination with capacitively coupled contactless conductivity detection (CE-C(4)D) was used due to lack of UV absorbance property of trifluoroacetic acid (TFA)."( Method development and validation for trifluoroacetic acid determination by capillary electrophoresis in combination with capacitively coupled contactless conductivity detection (CE-C4D).
Adams, E; El-Attug, MN; Hoogmartens, J; Lutumba, B; Van Schepdael, A, 2010
)
0.83

Bioavailability

ExcerptReferenceRelevance
"An assay for the quantification of plasma and urine levels of CVS 1123, an orally bioavailable thrombin inhibitor, and its desmethyl form."( Quantitation of an orally available thrombin inhibitor in rat, monkey and human plasma and in human urine by high-performance liquid chromatography and fluorescent post-column derivatization of arginine.
Dixon, SA; Lods, MM; Ma, MG; Mendoza, CB; Nguyen, KT; Nolan, TG; Nutt, RF; Tran, HS, 1997
)
0.3

Dosage Studied

ExcerptRelevanceReference
" Plasma concentration data following one 25-mg dose of phenylpropanolamine hydrochloride in four healthy volunteers illustrates the suitability of this analytical method for monitoring plasma levels after oral administration of a typical dosage form."( Electron-capture capillary gas chromatographic determination of phenylpropanolamine in human plasma following derivatization with trifluoroacetic anhydride.
Bayne, WF; Crisologo, N; Dye, D, 1984
)
0.27
" Before it can be used, however, particularly as a propellant in an aerosol pharmaceutical formulation whereby the compound is in effect dosed to people, it is important that the safety of this compound is established."( The minimal metabolism of inhaled 1,1,1,2-tetrafluoroethane to trifluoroacetic acid in man as determined by high sensitivity 19F nuclear magnetic resonance spectroscopy of urine samples.
Ismail, I; Mallett, DN; Matthews, C; Monté, SY; Tanner, RJ, 1994
)
0.53
" Furthermore, given that the PBPK model adequately describes the kinetics of halothane in rats and humans and of HCFC-123 in rats, use of the human PBPK model is proposed for deriving dose-response estimates of human health risks in the absence of human kinetic data."( Rat to human extrapolation of HCFC-123 kinetics deduced from halothane kinetics: a corollary approach to physiologically based pharmacokinetic modeling.
Fisher, JW; Jarabek, AM; McDougal, JN; Vinegar, A; Williams, RJ, 1996
)
0.29
" These results indicate that the method can be successfully used in order to assay SCD in a nanoemulsion dosage form, and that this formulation has a protective effect over SCD degradation."( Development of a stability-indicating LC method for determination of a synthetic chalcone derivative in a nanoemulsion dosage form and identification of the main photodegradation product by LC-MS.
Andrighetti-Frohner, CR; Barreto, F; Deponti, VB; Koester, LS; Mattos, CB; Nunes, RJ; Simões, CM; Steindel, M; Teixeira, HF, 2012
)
0.38
" The method was fully validated for the determination of S-isomers of each drug in their dosage form."( High performance liquid chromatography with photo diode array for separation and analysis of naproxen and esomeprazole in presence of their chiral impurities: Enantiomeric purity determination in tablets.
El-Kimary, EI; Ragab, MAA, 2017
)
0.46
" The proposed method was successfully applied for the determination of both drugs in tablets dosage form without interference from the commonly encountered excipients."( Digitally enhanced thin layer chromatography for simultaneous determination of norfloxacin and tinidazole with the aid of Taguchi orthogonal array and desirability function approach: Greenness assessment by analytical Eco-Scale.
Hemdan Abou-Taleb, N; Ibrahim El-Subbagh, H; Mahmoud El-Enany, N; Tawfik El-Sherbiny, D, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
reagentA substance used in a chemical reaction to detect, measure, examine, or produce other substances.
human xenobiotic metaboliteAny human metabolite produced by metabolism of a xenobiotic compound in humans.
NMR chemical shift reference compoundAny compound that produces a peak used to reference an NMR spectrum during data pre-processing.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
fluoroalkanoic acidAny organofluorine compound that is the perfluorinated derivative of any alkanoic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Ethanol metabolism resulting in production of ROS by CYP2E1117
Ethanol metabolism production of ROS by CYP2E1117

Bioassays (3)

Assay IDTitleYearJournalArticle
AID342464Dissociation constant, pKa of the compound2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
The many roles for fluorine in medicinal chemistry.
AID448096Dissociation constant, pKa of the compound2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Characterization of alpha-nitromethyl ketone as a new zinc-binding group based on structural analysis of its complex with carboxypeptidase A.
AID728441Binding affinity to Enterobacteria phage T4 lysozyme L99A/M102H double mutant expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 5 mM at pH 5.4 by circular dichroism analysis2013Journal of medicinal chemistry, Apr-11, Volume: 56, Issue:7
The impact of introducing a histidine into an apolar cavity site on docking and ligand recognition.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,245)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990222 (17.83)18.7374
1990's216 (17.35)18.2507
2000's365 (29.32)29.6817
2010's358 (28.76)24.3611
2020's84 (6.75)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 88.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index88.29 (24.57)
Research Supply Index7.18 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index160.89 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (88.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials7 (0.53%)5.53%
Reviews25 (1.91%)6.00%
Case Studies12 (0.92%)4.05%
Observational0 (0.00%)0.25%
Other1,265 (96.64%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]